Experts debate the role of pharmacy benefit managers in rising U.S. drug prices.
Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.
Biden Administration introduces price regulation to the pharmaceutical industry.
Two scholars find that the removal of FDA health warnings prompts an increase in drug marketing.
The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States.
CMS reconsiders a recent Medicare premium increase after restricting coverage for a controversial new drug.
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.
Experts consider how regulators can make drugs affordable without hindering research and development.
A federal task force proposes regulatory solutions to mitigate drug shortages.
The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.